Dengue Vaccine Market Report 2026
Download Free Sample Buy Now
Dengue Vaccine Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Dengue Vaccine Market Report 2026

Global Outlook – By Type (Live Attenuated Vaccine, Chimeric Live Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccine, Nucleic Acid Based Vaccine), By Vaccine Phase (Phase I, Phase II, Phase III), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By End-User (Hospitals, Clinics, Government Institutes, Non-Governmental Organizations, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Dengue Vaccine Market Overview

• Dengue Vaccine market size has reached to $0.51 billion in 2025

• Expected to grow to $1.16 billion in 2030 at a compound annual growth rate (CAGR) of 17.3%

• Growth Driver: Surge In Dengue Fever Cases Fuels Growth In The Dengue Vaccine Market

• Market Trend: Phase 3 Trial Targets Long-Lasting Protection Against All Dengue Serotypes

• Asia-Pacific was the largest region in 2025 and North America is the fastest growing region.

What Is Covered Under Dengue Vaccine Market?

A dengue vaccine is a biological preparation designed to prevent dengue fever, a mosquito-borne viral disease caused by the dengue virus (DENV). If exposed in the future, dengue Vaccines stimulate the body's immune system to recognize and fight off the dengue virus.

The main types of dengue vaccines are live attenuated vaccine, chimeric live attenuated vaccine, inactivated vaccine, subunit vaccine, and nucleic acid-based vaccine. Live-attenuated vaccines use a weakened virus to trigger an immune response, preparing the body to combat dengue without causing the disease. It includes different vaccine phases, such as phase I, phase II, and phase III, with treatment including diuretics, anti-allergics, blood thinners, and others. It is administered through several routes of administration, such as oral, parenteral, and others, and used by end-user hospitals, clinics, government institutes, non-governmental organizations, and others.

Dengue Vaccine market report bar graph

What Is The Dengue Vaccine Market Size and Share 2026?

The dengue vaccine market size has grown exponentially in recent years. It will grow from $0.51 billion in 2025 to $0.61 billion in 2026 at a compound annual growth rate (CAGR) of 20.2%. The growth in the historic period can be attributed to rising dengue infection rates, limited availability of early vaccines, increased public health burden, growing awareness of mosquito-borne diseases, early government intervention programs.

What Is The Dengue Vaccine Market Growth Forecast?

The dengue vaccine market size is expected to see rapid growth in the next few years. It will grow to $1.16 billion in 2030 at a compound annual growth rate (CAGR) of 17.3%. The growth in the forecast period can be attributed to expansion of immunization programs, increasing investment in vaccine research, rising healthcare spending in endemic countries, growing focus on multi-strain vaccine efficacy, accelerated regulatory approvals. Major trends in the forecast period include rising global focus on dengue prevention, increasing government-led vaccination programs, growing adoption of tetravalent dengue vaccines, expansion of public health funding in endemic regions, rising demand for pediatric immunization solutions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global  Dengue Vaccine Market Segmentation

1) By Type: Live Attenuated Vaccine, Chimeric Live Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccine, Nucleic Acid Based Vaccine

2) By Vaccine Phase: Phase I, Phase II, Phase III

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

4) By End-User: Hospitals, Clinics, Government Institutes, Non-Governmental Organizations, Other End-Users

Subsegments:

1) By Live Attenuated Vaccine: Single Strain, Multi-Strain

2) By Chimeric Live Attenuated Vaccine: Tetravalent Chimeric Vaccine, Monovalent Chimeric Vaccine

3) By Inactivated Vaccine: Whole Virus Inactivated Vaccine, Split Virus Vaccine

4) By Subunit Vaccine: Recombinant Protein Vaccine, Peptide-Based Vaccine

5) By Nucleic Acid Based Vaccine: DNA Vaccine, mRNA Vaccine

What Is Driver Of The Dengue Vaccine  Market?

The rising number of dengue fever cases is expected to propel the growth of the dengue vaccine markets going forward. Dengue fever is a viral infection spread by Aedes aegypti mosquitoes, causing high fever, headaches, joint pain, and rashes. The rise in dengue fever cases is due to climate change, urbanization, inadequate mosquito control, and viral evolution. The dengue vaccine works by activating the immune system to identify and combat the dengue virus. It lessens infection severity and reduces the risk of severe complications, helping to decrease cases and hospitalizations. For instance, in May 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, in the American region, dengue cases surpassed 7 million in April 2024, from 4.6 million cases reported in 2023. Therefore, the rising number of dengue fever cases is driving the growth of the dengue vaccine industry.

Key Players In The Global Dengue Vaccine Market

Major companies operating in the dengue vaccine market are Merck & Co. Inc., Sanofi Pasteur Limited, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Biological E. Limited, Saint Louis University, Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Instituto Butantan, Bharat Biotech Ltd., Panacea Biotec Limited, SABIN Vaccine Institute, Medigen Vaccine Biologics Corporation, Emergex Vaccines Holding Ltd., BioNet-Asia Co. Ltd., Codagenix Inc., KM Biologics Co. Ltd., Chula Vaccine Research Center, Imutex Ltd.

Global Dengue Vaccine Market Trends and Insights

Major companies operating in the dengue vaccine market are focused on conducting clinical trials to develop innovative formulations such as live attenuated vaccines to provide broad, long-lasting protection against all four dengue virus serotypes. Live attenuated vaccines are made from a weakened form of the virus that cannot cause disease in healthy individuals but stimulates the immune system to develop strong, long-lasting, and broad protection, enabling the body to recognize and fight the real virus effectively if exposed in the future. For instance, in June 2025, Merck & Co. Inc., a US-based pharmaceutical company, initiated the MOBILIZE-1 Phase 3 clinical trial to evaluate V181, its investigational live attenuated quadrivalent dengue vaccine. The study aims to enroll approximately 12,000 healthy children and adolescents aged 2 to 17 in dengue-endemic countries across the Asia-Pacific region, including Indonesia, Malaysia, Philippines, Singapore, Thailand, and Vietnam. The trial is designed as a randomized, double-blind, placebo-controlled study to assess the safety, immunogenicity, and efficacy of a single dose of V181 against all four dengue virus serotypes, regardless of prior dengue exposure. The vaccine targets symptomatic dengue of any severity, including severe forms that may require hospitalization, and seeks to provide broad, long-lasting protection to reduce the global burden of this rapidly spreading mosquito-borne disease.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Dengue Vaccine Market? Takeda Partnered With Biological E. Limited To Boost Dengue Vaccine Production And Accessibility

In February 2024, Takeda Pharmaceutical Company, a Japan-based manufacturer of dengue vaccine, partnered with Biological E. Limited. Through this collaboration, Takeda aims to accelerate the production and accessibility of the dengue vaccine QDENGA (TAK-003) in endemic regions by increasing manufacturing capacity and providing multi-dose vials to support national immunization programs. Biological E. Limited is an India-based biotechnology and biopharmaceutical company specializing in producing and supplying vaccines and therapeutics.

Regional Outlook

Asia-Pacific was the largest region in the dengue vaccine market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Dengue Vaccine Market?

The dengue vaccine market consists of revenues earned by entities by providing treatment such as chlorothiazide, chlorthalidone, hydrochlorothiazide, and fexofenadine. The market value includes the value of related goods sold by the service provider or included within the service offering. The dengue vaccine market also includes sales of diagnostic kits, combination vaccines, clinical trial products, and post-vaccination monitoring tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Dengue Vaccine Market Report 2026?

The dengue vaccine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the dengue vaccine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Girish Kavali

Dengue Vaccine Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $0.61 billion
Revenue Forecast In 2035 $5.72 billion
Growth Rate CAGR of 20.2% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Vaccine Phase, Route Of Administration, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Merck & Co. Inc., Sanofi Pasteur Limited, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Biological E. Limited, Saint Louis University, Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Instituto Butantan, Bharat Biotech Ltd., Panacea Biotec Limited, SABIN Vaccine Institute, Medigen Vaccine Biologics Corporation, Emergex Vaccines Holding Ltd., BioNet-Asia Co. Ltd., Codagenix Inc., KM Biologics Co. Ltd., Chula Vaccine Research Center, Imutex Ltd.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Dengue Vaccine Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Dengue Vaccine Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Dengue Vaccine Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Dengue Vaccine Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Global Focus On Dengue Prevention

4.2.2 Increasing Government-Led Vaccination Programs

4.2.3 Growing Adoption Of Tetravalent Dengue Vaccines

4.2.4 Expansion Of Public Health Funding In Endemic Regions

4.2.5 Rising Demand For Pediatric Immunization Solutions

5. Dengue Vaccine Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Government Institutes

5.4 Non-Governmental Organizations

5.5 Research Institutions

6. Dengue Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Dengue Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Dengue Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Dengue Vaccine Market Size, Comparisons And Growth Rate Analysis

7.3. Global Dengue Vaccine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Dengue Vaccine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Dengue Vaccine Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Dengue Vaccine Market Segmentation

9.1. Global Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Live Attenuated Vaccine, Chimeric Live Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccine, Nucleic Acid Based Vaccine

9.2. Global Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Phase I, Phase II, Phase III

9.3. Global Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Parenteral, Other Routes Of Administration

9.4. Global Dengue Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Government Institutes, Non-Governmental Organizations, Other End-Users

9.5. Global Dengue Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Single Strain, Multi-Strain

9.6. Global Dengue Vaccine Market, Sub-Segmentation Of Chimeric Live Attenuated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tetravalent Chimeric Vaccine, Monovalent Chimeric Vaccine

9.7. Global Dengue Vaccine Market, Sub-Segmentation Of Inactivated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Whole Virus Inactivated Vaccine, Split Virus Vaccine

9.8. Global Dengue Vaccine Market, Sub-Segmentation Of Subunit Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Recombinant Protein Vaccine, Peptide-Based Vaccine

9.9. Global Dengue Vaccine Market, Sub-Segmentation Of Nucleic Acid Based Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

DNA Vaccine, mRNA Vaccine

10. Dengue Vaccine Market Regional And Country Analysis

10.1. Global Dengue Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Dengue Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Dengue Vaccine Market

11.1. Asia-Pacific Dengue Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Dengue Vaccine Market

12.1. China Dengue Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Dengue Vaccine Market

13.1. India Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Dengue Vaccine Market

14.1. Japan Dengue Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Dengue Vaccine Market

15.1. Australia Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Dengue Vaccine Market

16.1. Indonesia Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Dengue Vaccine Market

17.1. South Korea Dengue Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Dengue Vaccine Market

18.1. Taiwan Dengue Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Dengue Vaccine Market

19.1. South East Asia Dengue Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Dengue Vaccine Market

20.1. Western Europe Dengue Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Dengue Vaccine Market

21.1. UK Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Dengue Vaccine Market

22.1. Germany Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Dengue Vaccine Market

23.1. France Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Dengue Vaccine Market

24.1. Italy Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Dengue Vaccine Market

25.1. Spain Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Dengue Vaccine Market

26.1. Eastern Europe Dengue Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Dengue Vaccine Market

27.1. Russia Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Dengue Vaccine Market

28.1. North America Dengue Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Dengue Vaccine Market

29.1. USA Dengue Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Dengue Vaccine Market

30.1. Canada Dengue Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Dengue Vaccine Market

31.1. South America Dengue Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Dengue Vaccine Market

32.1. Brazil Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Dengue Vaccine Market

33.1. Middle East Dengue Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Dengue Vaccine Market

34.1. Africa Dengue Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Dengue Vaccine Market, Segmentation By Type, Segmentation By Vaccine Phase, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Dengue Vaccine Market Regulatory and Investment Landscape

36. Dengue Vaccine Market Competitive Landscape And Company Profiles

36.1. Dengue Vaccine Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Dengue Vaccine Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Dengue Vaccine Market Company Profiles

36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Sanofi Pasteur Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Takeda Pharmaceutical Company Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Biological E. Limited Overview, Products and Services, Strategy and Financial Analysis

37. Dengue Vaccine Market Other Major And Innovative Companies

Saint Louis University, Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Instituto Butantan, Bharat Biotech Ltd., Panacea Biotec Limited, SABIN Vaccine Institute, Medigen Vaccine Biologics Corporation, Emergex Vaccines Holding Ltd., BioNet-Asia Co. Ltd., Codagenix Inc., KM Biologics Co. Ltd., Chula Vaccine Research Center, Imutex Ltd.

38. Global Dengue Vaccine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Dengue Vaccine Market

40. Dengue Vaccine Market High Potential Countries, Segments and Strategies

40.1 Dengue Vaccine Market In 2030 - Countries Offering Most New Opportunities

40.2 Dengue Vaccine Market In 2030 - Segments Offering Most New Opportunities

40.3 Dengue Vaccine Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Dengue Vaccine Market, Overview Of Key Products - Product Examples
  • Table 2: Global Dengue Vaccine Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Dengue Vaccine Market, Supply Chain Analysis
  • Table 4: Global Dengue Vaccine Market, Major Raw Material Providers
  • Table 5: Global Dengue Vaccine Market, Major Resource Providers
  • Table 6: Global Dengue Vaccine Market, Major Manufacturers (Suppliers)
  • Table 7: Global Dengue Vaccine Market, Major Distributors And Channel Partners
  • Table 8: Global Dengue Vaccine Market, Key Technologies & Future Trends
  • Table 9: Global Dengue Vaccine Market, Major Trends
  • Table 10: Global Dengue Vaccine Market, Major End Users
  • Table 11: Global Dengue Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Dengue Vaccine Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Dengue Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Dengue Vaccine Market - TAM, US$ Billion, 2025
  • Table 15: Global Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Dengue Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Dengue Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Dengue Vaccine Market, Sub-Segmentation Of Chimeric Live Attenuated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Dengue Vaccine Market, Sub-Segmentation Of Inactivated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Dengue Vaccine Market, Sub-Segmentation Of Subunit Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Dengue Vaccine Market, Sub-Segmentation Of Nucleic Acid Based Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Dengue Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Dengue Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Global Dengue Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 99: Global Dengue Vaccine Market - Company Scoring Matrix
  • Table 100: Merck & Co. Inc. Financial Performance
  • Table 101: Sanofi Pasteur Limited Financial Performance
  • Table 102: GlaxoSmithKline plc Financial Performance
  • Table 103: Takeda Pharmaceutical Company Financial Performance
  • Table 104: Biological E. Limited Financial Performance
  • Table 105: Global Dengue Vaccine Market, Competitive Benchmarking (In USD Billions)
  • Table 106: Global Dengue Vaccine Market, Competitive Dashboard
  • Table 107: Global Dengue Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 108: Global, Dengue Vaccine Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 109: Global, Dengue Vaccine Market Size Gain ($ Billion), Segmentation By Vaccine Phase, 2025 – 2030
  • Table 110: Global, Dengue Vaccine Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

    Figure 1: Global Dengue Vaccine Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Dengue Vaccine Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Dengue Vaccine Market, Supply Chain Analysis
  • Figure 4: Global Dengue Vaccine Market, Major Raw Material Providers
  • Figure 5: Global Dengue Vaccine Market, Major Resource Providers
  • Figure 6: Global Dengue Vaccine Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Dengue Vaccine Market, Major Distributors And Channel Partners
  • Figure 8: Global Dengue Vaccine Market, Key Technologies & Future Trends
  • Figure 9: Global Dengue Vaccine Market, Major Trends
  • Figure 10: Global Dengue Vaccine Market, Major End Users
  • Figure 11: Global Dengue Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Dengue Vaccine Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Dengue Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Dengue Vaccine Market - TAM, US$ Billion, 2025
  • Figure 15: Global Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Dengue Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Dengue Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Dengue Vaccine Market, Sub-Segmentation Of Chimeric Live Attenuated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Dengue Vaccine Market, Sub-Segmentation Of Inactivated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Dengue Vaccine Market, Sub-Segmentation Of Subunit Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Dengue Vaccine Market, Sub-Segmentation Of Nucleic Acid Based Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Dengue Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Dengue Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Global Dengue Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 99: Global Dengue Vaccine Market - Company Scoring Matrix
  • Figure 100: Merck & Co. Inc. Financial Performance
  • Figure 101: Sanofi Pasteur Limited Financial Performance
  • Figure 102: GlaxoSmithKline plc Financial Performance
  • Figure 103: Takeda Pharmaceutical Company Financial Performance
  • Figure 104: Biological E. Limited Financial Performance
  • Figure 105: Global Dengue Vaccine Market, Competitive Benchmarking (In USD Billions)
  • Figure 106: Global Dengue Vaccine Market, Competitive Dashboard
  • Figure 107: Global Dengue Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 108: Global, Dengue Vaccine Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 109: Global, Dengue Vaccine Market Size Gain ($ Billion), Segmentation By Vaccine Phase, 2025 – 2030
  • Figure 110: Global, Dengue Vaccine Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Explore TBRC insights on sustainability trends, capacity expansion, and growth drivers in the RAS Market.

Read More About Explore TBRC insights on sustainability trends, capacity expansion, and growth drivers in the RAS Market.

Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant...

Automotive E-Tailing Market Report 2026 - Global Outlook – By Component (Electrical Products, Engine Components, Infotainment, Interior Accessories, Tires), By Vehicle Type (Two-Wheeler, Passenger Vehicle, Commercial), B...

Erdheim Chester Disease Market Report 2026 - Global Outlook – By Treatment (Chemotherapy, Immunotherapy, Radiation Therapy, Other Treatments), By Route Of Administration (Oral, Parenteral, Other Route Of Administrations)...

Automotive E-Tailing Market Report 2026 - Global Outlook – By Component (Electrical Products, Engine Components, Infotainment, Interior Accessories, Tires), By Vehicle Type (Two-Wheeler, Passenger Vehicle, Commercial), B...

Automatic Effluent Samplers Market Report 2026 - Global Outlook – By Product Type (Portable Samplers, Stationary Samplers), By Distribution Channel (Direct Sales, Distributors), By Application (Industrial Wastewater, Mun...

Embedded Computing Market Report 2026 - Global Outlook – By Type (Hardware, Software), By Function (Real-Time, Standalone, Mobile, Networked), By End User (Automotive, Industrial, Healthcare, Retail, Consumer And Smart H...

Audience Intelligence Platform Market Report 2026 - Global Outlook – By Type of Platform (Content Intelligence Platforms, Social Media Intelligence Platforms), By Deployment Type (On-Premise, Cloud), By Application (Gove...

Frequently Asked Questions

The Dengue Vaccine market was valued at $0.51 billion in 2025, increased to $0.61 billion in 2026, and is projected to reach $1.16 billion by 2030.

The global Dengue Vaccine market is expected to grow at a CAGR of 17.3% from 2026 to 2035 to reach $1.16 billion by 2035.

Some Key Players in the Dengue Vaccine market Include, Merck & Co. Inc., Sanofi Pasteur Limited, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Biological E. Limited, Saint Louis University, Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Instituto Butantan, Bharat Biotech Ltd., Panacea Biotec Limited, SABIN Vaccine Institute, Medigen Vaccine Biologics Corporation, Emergex Vaccines Holding Ltd., BioNet-Asia Co. Ltd., Codagenix Inc., KM Biologics Co. Ltd., Chula Vaccine Research Center, Imutex Ltd. .

Major trend in this market includes: Phase 3 Trial Targets Long-Lasting Protection Against All Dengue Serotypes. For further insights on this market. request a sample here

Asia-Pacific was the largest region in the dengue vaccine market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the dengue vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us